Combinostics

Finland Founded: 2014 • Age: 12 yrs Acquired By SyntheticMR
AI-powered solutions for neurological disorder detection and management are developed.

About Combinostics

Combinostics is a company based in Finland founded in 2014 by Jussi Mattila, Jyrki Lotjonen, and Lennart Thurfjell was acquired by SyntheticMR in November 2024.. Combinostics has raised $4.3 million across 5 funding rounds from investors including European Union, SyntheticMR and Industrifonden. The company has 3 employees as of December 31, 2022. Combinostics offers products and services including cNeuro Platform, cMRI, cDSI, and cPET and cDAT. Combinostics operates in a competitive market with competitors including Medical Brain, Neurobrave, Nile, iMed Technologies and RedOak Instruments, among others.

  • Headquarter Finland
  • Employees 3 as on 31 Dec, 2022
  • Founders Jussi Mattila, Jyrki Lotjonen, Lennart Thurfjell
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Combinostics Us Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.3 M (USD)

    in 5 rounds

  • Latest Funding Round
    $475.32 K (USD), Grant

    Jan 01, 2021

  • Investors
  • Employee Count
    3

    as on Dec 31, 2022

  • Acquired by
    SyntheticMR

    (Nov 28, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Combinostics

Combinostics offers a comprehensive portfolio of products and services, including cNeuro Platform, cMRI, cDSI, and cPET and cDAT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Comprehensive platform for managing neurological disorders via data integration.

Fully automated tool for brain MRI analysis and abnormality detection.

AI system for differential diagnosis using patient data and imaging.

Tools for quantifying SPECT images and supporting nuclear medicine diagnostics.

People of Combinostics
Headcount 10-50
Employee Profiles 11
Employee Profiles
People
Yuliia Tsvietkova
Marketing Project Coordinator
People
Antti Tolonen
Data Scientist
People
Jyrki Lötjönen
CSO
People
Markus Niiranen
Senior Software Engineer, Co-founder

Unlock access to complete

Funding Insights of Combinostics

Combinostics has successfully raised a total of $4.3M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $475.32 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Grant — $475,318
  • First Round
  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Grant - Combinostics Valuation

investors

Jan, 2020 Amount Grant - Combinostics Valuation

investors

Nov, 2019 Amount Series A - Combinostics Valuation Industrifonden , NordicNinja
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Combinostics

Combinostics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SyntheticMR and Industrifonden. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments in deep-tech, life sciences, and transformative tech are managed.
Founded Year Domain Location
A venture capital firm investing in sustainable and deep-tech startups
Founded Year Domain Location
CakhiaTV is operated as a football streaming and news platform.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Combinostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Combinostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Combinostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Combinostics

Combinostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medical Brain, Neurobrave, Nile, iMed Technologies and RedOak Instruments, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Actionable insights for neurological conditions are generated via AI platform.
domain founded_year HQ Location
Cloud-based neurology disease detection tool for healthcare professionals
domain founded_year HQ Location
AI-based epilepsy management tools are provided to patients and providers.
domain founded_year HQ Location
Developer of AI-based video analysis technology for surgery support
domain founded_year HQ Location
Developer of device for injury and motor skills monitoring
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Combinostics

Frequently Asked Questions about Combinostics

When was Combinostics founded?

Combinostics was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Combinostics located?

Combinostics is headquartered in Finland.

Who is the current CEO of Combinostics?

Lennart Thurfjell is the current CEO of Combinostics. They have also founded this company.

Is Combinostics a funded company?

Combinostics is a funded company, having raised a total of $4.3M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.3M, raised on May 13, 2016.

How many employees does Combinostics have?

As of Dec 31, 2022, the latest employee count at Combinostics is 3.

What does Combinostics do?

Combinostics was founded in 2014 in Finland, with operations centered on AI applications in the healthcare sector. Neurological disorders such as dementia, multiple sclerosis, traumatic brain injury, and epilepsy are addressed through the cloud-based cNeuro platform. Products including cNeuro cMRI and cNeuro cDSI are integrated with external data sources to support comprehensive patient management, diagnosis, and detection processes.

Who are the top competitors of Combinostics?

Combinostics's top competitors include Medical Brain, Nile and Neurobrave.

What products or services does Combinostics offer?

Combinostics offers cNeuro Platform, cMRI, cDSI, and cPET and cDAT.

Who are Combinostics's investors?

Combinostics has 5 investors. Key investors include European Union, SyntheticMR, Industrifonden, NordicNinja, and CakhiaTV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available